The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.

• AbbVie's third-quarter results exceeded Wall Street's expectations.

• Sales from the pharmaceutical company's 3 apical drugs are soaring.

• 10 stocks we similar amended than AbbVie ›

Pharmaceutical stocks person been connected occurrence this year. The iShares U.S. Pharmaceuticals ETF (NYSEMKT: IHE), which tracks 43 drugmakers, is up astir 29% twelvemonth to day and 11% implicit the past month.

There are tons of large stocks successful this sector. But 1 that investors should beryllium watching intimately close present is AbbVie (NYSE: ABBV). The institution is focused connected drugs that dainty a scope of diseases successful the areas of immunology, rheumatology, gastroenterology, dermatology, and oncology, among others.

The institution released its quarterly results connected Oct. 31, and they exceeded Wall Street's forecasts. Sales climbed 9.1% to $15.78 billion, which was importantly higher than the $15.59 cardinal expected. The institution posted net of $1.86 per share, 11 cents supra the $1.77 expected.

AbbVie has a beardown unchangeable of top-performing drugs. Sales of Skyrizi, an immunology cause that treats conditions similar psoriasis and arthritis, roseate a whopping 46.8% to $4.7 cardinal during the quarter. Sales of Rinvoq, a akin immunology drug, climbed 35.3% to $2.18 billion. And Humira, which is utilized to dainty plaque psoriasis, brought gross of $993 million, up 55.4% from a twelvemonth ago.

Management said it believes Rinvoq volition deed $11 cardinal successful yearly gross by 2027, and Skyrizi volition scope the $20 cardinal mark. AbbVie's existent unchangeable of best-selling drugs is impressive, portion it continues to grow its pipeline with acquisitions. This is simply a blistery banal successful a blistery assemblage good worthy watching.

Before you bargain banal successful AbbVie, see this:

The Motley Fool Stock Advisor expert squad conscionable identified what they judge are the 10 champion stocks for investors to bargain now… and AbbVie wasn’t 1 of them. The 10 stocks that made the chopped could nutrient monster returns successful the coming years.

Consider erstwhile Netflix made this database connected December 17, 2004... if you invested $1,000 astatine the clip of our recommendation, you’d person $540,587!* Or erstwhile Nvidia made this database connected April 15, 2005... if you invested $1,000 astatine the clip of our recommendation, you’d person $1,118,210!*

Now, it’s worthy noting Stock Advisor’s full mean instrumentality is 991% — a market-crushing outperformance compared to 195% for the S&P 500. Don't miss the latest apical 10 list, disposable with Stock Advisor, and articulation an investing assemblage built by idiosyncratic investors for idiosyncratic investors.